Recently I am researching about IRON-OXIDE NANOPARTICLES; IN-VIVO APPLICATIONS; BIOMEDICAL APPLICATIONS; SURFACE MODIFICATION; CANCER THERANOSTICS; DELIVERY; DOXORUBICIN; VITRO; SPIONS; MR, Saw an article supported by the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51703174]; Hubei Province Science Foundation for Youths [2017CFB154]; Startup Foundation of Chutian Scholars by Wuhan University of Science and Technology [040288]; Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [cxpy2016021]. Product Details of 56-17-7. Published in ELSEVIER SCI LTD in OXFORD ,Authors: Peng, N; Ding, X; Wang, ZY; Cheng, Y; Gong, ZW; Xu, XJ; Gao, XF; Cai, Q; Huang, SW; Liu, Y. The CAS is 56-17-7. Through research, I have a further understanding and discovery of 2,2′-Disulfanediyldiethanamine dihydrochloride
The aim of this work was to obtain a novel onco-theranostic system for early diagnosis and improved chemotherapeutic outcome. Hybrid nanogels with magnetic and dual responsive properties were fabricated by covalently attaching superparamagnetic iron oxide nanoparticles (SPIONs) with a disulfide-modified alginate derivative, while simultaneously encapsulating the anticancer drug doxorubicin. The resulting nanogels exhibited magnetic-targeted characteristics, high drug loading content, co-triggered release behavior, high toxicity to tumor cells, low side effects to normal cells, and magnetic resonance imaging (MRI) functions. These findings proved that the hybrid nanogels have great potential as novel tumor-targeting nano-theranostic agents for simultaneous MRI imaging and efficient anti-tumor treatment.
About 2,2′-Disulfanediyldiethanamine dihydrochloride, If you have any questions, you can contact Peng, N; Ding, X; Wang, ZY; Cheng, Y; Gong, ZW; Xu, XJ; Gao, XF; Cai, Q; Huang, SW; Liu, Y or concate me.. Product Details of 56-17-7
Reference:
Thiazine – an overview | ScienceDirect Topics,
,Thiazine | C4H5NS – PubChem